BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activationMeike Vogler, Gerald M. Cohen|Blood|2011Cited by 189
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Evelyn Ullrich, Nina Möker et al.|Nature Communications|2024Cited by 71
CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AMLNawid Albinger, Evelyn Ullrich, Tobias Bexte et al.|Blood|2022Cited by 22
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapyLisa Marie Reindl, Evelyn Ullrich, Lida Jalili et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYCNadja M. Pieper, Meike Vogler|Cell Communication and Signaling|2024Cited by 3